Olema Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
OLMA Nasdaq 2836 olema.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Olema Pharmaceuticals, Inc.

Olema Insider Sells $8 Million in Shares After 300% Stock Surge - Jan 9th, 2026 9:28 am
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors - Jan 8th, 2026 7:09 pm
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 5th, 2026 2:30 pm
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference - Jan 5th, 2026 5:00 am
Olema (OLMA) Hits 4-Year High as Jefferies Hikes PT - Dec 11th, 2025 8:19 am
This strategist is 'following the money' on these stock picks - Nov 24th, 2025 3:45 pm
Olema Pharmaceuticals (OLMA): Evaluating the Current Valuation After a Strong Run-Up in Recent Months - Nov 24th, 2025 12:08 am
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - Nov 21st, 2025 2:30 pm
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Nov 20th, 2025 2:01 pm
Olema Pharmaceuticals Has Nearly Tripled on Cancer Drug Hopes. How Should You Play OLMA Stock Here? - Nov 19th, 2025 9:50 am
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock - Nov 19th, 2025 5:00 am
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Nov 19th, 2025 4:14 am
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Nov 18th, 2025 2:51 pm
Why Roche's Positive Test Results Sent Olema Pharma Skyrocketing 130% - Nov 18th, 2025 2:09 pm
BC-Most Active Stocks - Nov 18th, 2025 8:30 am
Olema Oncology Reports Third Quarter 2025 Financial and Operating Results - Nov 10th, 2025 5:00 am
Olema Oncology to Participate in Upcoming Investor Conferences - Nov 3rd, 2025 2:30 pm
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025 - Oct 30th, 2025 2:30 pm
Olema Pharmaceuticals Shares Fall After Roche's Breast Cancer Data Weighs on Sector - Oct 20th, 2025 9:25 am
Wall Street Set to Open Higher Monday as Investors Look Ahead to a Week of Earnings Reports - Oct 20th, 2025 7:27 am